Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on August 5, 2026

Aug. 5, 2026

Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial

Indeterminate GlobeNewswire

Aug. 5, 2026

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

AC Immune First Half 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

BioCryst Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments

Indeterminate GlobeNewswire

Aug. 5, 2026

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 5, 2026

Entrada Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs

Indeterminate GlobeNewswire

Aug. 5, 2026

Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire

Aug. 5, 2026

Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 5, 2026

Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue

Indeterminate GlobeNewswire

Aug. 5, 2026

Shopify Delivers Big: 30%+ Growth Across GMV, Revenue, Gross Profit, and Free Cash Flow

Indeterminate GlobeNewswire

Aug. 5, 2026

Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy

Indeterminate GlobeNewswire

Aug. 5, 2026

Telix to Host R&D Day in New York City on September 22, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

Indeterminate GlobeNewswire